BDA Expands Senior Team: Sanjay Singh Joins as Head of BDA India

New York, NY, May 17, 2021 --(PR.com)-- BDA Partners is pleased to announce that Sanjay Singh has
joined the firm as Managing Director and Head of BDA, India. He will lead the Mumbai office with
BDA’s existing senior bankers in India. He will also co-head BDA’s Asian Healthcare team.

Sanjay has over 20 years’ experience in the healthcare sector. Before joining BDA, he was Partner and
Head of Life Sciences at KPMG India. He has a record of advising corporate and financial sponsor clients
on transactions in pharma, healthcare and chemicals. He has advised clients including Baxter, Isagro,
Johnson & Johnson, Nihon Nohyaku, Roquette, and SMT. Before KPMG, he worked at Glenmark
Pharmaceuticals and Dr Reddy’s Labs, in corporate development and global marketing roles.

Sanjay will join BDA India’s leadership team alongside two existing Managing Directors, Kumar
Mahtani and Manoj Balwani, who have been instrumental in building BDA’s practice. BDA has closed
Indian transactions for Actis, EQT, Flex, ICICI Venture, Larsen & Toubro, Nord Holdings, Partners
Group, Rich Foods, and Terex.

Kumar Mahtani will move forward as Head of Consumer & Industrial, India. Manoj Balwani will remain
as Head of Technology & Tech Services, India.

Sanjay Singh said: “BDA is enjoying a good growth trajectory in India, providing a strong value
proposition to both financial sponsors and strategic clients, and offering connectivity to the West and
across Asia. I’m pleased to join BDA in this exciting phase and look forward to adding value for BDA’s
blue-chip clients.”

Andrew Huntley, Managing Partner of BDA and Global Head of Healthcare, said: “India is a priority for
BDA. We anticipate continuing growth in M&A and private equity activity. With Sanjay joining, we have
a senior team of three MDs in Mumbai, offering coverage across our core sectors for corporates and
financial sponsors. BDA’s clients, especially in the Health sector, will benefit from Sanjay’s experience.
I’m grateful to Kumar and Manoj for their excellent ongoing work in building our India business.”

Kumar Mahtani, Managing Director, BDA Mumbai, said: “I’ve enjoyed working with Sanjay in the past,
and I’m excited to welcome him onboard. We’re bullish about the Indian market, especially cross-border
M&A. BDA India is well positioned for the next stage of growth.”

Manoj Balwani, Managing Director, BDA Mumbai, added: “I look forward to working with Sanjay and
Kumar to drive deal momentum, and to deliver excellent outcomes for our Indian and global clients.”

Recent select Indian transactions

- William Blair and BDA advise Partners Group on the sale of CSS Corp
- BDA advises Flex and Escientia Life Sciences on sale of Escientia to Deccan Fine Chemicals
- BDA advises Rich Products on the acquisition of Rich Graviss, India

Page 1/3
PR.com Press Release Distribution Terms of Use
About BDA
BDA Partners is the global investment banking advisor for Asia. We are a premium provider of
Asia-related advice to sophisticated clients globally, with over 20 years’ experience advising on
cross-border M&A, capital raising, and financial restructuring. We provide global reach with our teams in
New York and London, and true regional depth through our seven Asian offices in Mumbai, Singapore,
Ho Chi Minh City, Hong Kong, Shanghai, Seoul and Tokyo. BDA has deep expertise in the Chemicals,
Consumer & Retail, Health, Industrials, Services and Technology sectors. We work relentlessly to earn
our clients’ trust by delivering insightful advice and outstanding outcomes.

BDA Partners has strategic partnerships with William Blair, a premier global investment banking
business, and with DBJ (Development Bank of Japan), a Japanese government-owned bank with
US$150bn of assets.

US securities transactions are performed by BDA Partners’ affiliate, BDA Advisors Inc., a broker-dealer
registered with the Securities and Exchange Commission (SEC). BDA Advisors Inc. is a member of the
Financial Industry Regulatory Authority (FINRA) and SIPC. In the UK, BDA Partners is authorised and
regulated by the Financial Conduct Authority (FCA). In Hong Kong, BDA Partners (HK) Ltd. is licensed
and regulated by the Securities & Futures Commission (SFC) to conduct Type 1 and Type 4 regulated
activities to professional investors. www.bdapartners.com

Page 2/3
PR.com Press Release Distribution Terms of Use
Contact Information:
BDA Partners
Euan Rellie
212-265-5300
Contact via Email
www.bdapartners.com

Online Version of Press Release:

You can read the online version of this press release at: https://www.pr.com/press-release/836652

Page 3/3
PR.com Press Release Distribution Terms of Use